FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.
PBMs made billions marking up speciality drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in revenue from 2017 to 2022, according to a report issued by the Federal Trade Commission (FTC) on Tuesday.
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.
FTC releases second report slamming pharmacy benefit managers
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%
The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs than it cost them.
FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain
Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments
FTC says ‘Big 3 PBMs’ marked up generic drugs by thousands of percent
The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry, which it says focuses on
FTC Release: FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Report finds PBMs charge significant markups for cancer, HIV, and other critical specialty generic drugs The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry,
Apartment giant Greystar facing FTC lawsuit over misleading rental fees
The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.
Will ‘click to cancel’ get canceled? New FTC rule faces legal, political challenges
It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition ...
Federal Trade Commission accuses Greystar of deceptive practices, hidden fees
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.
Accounting Today13h
FTC mandates changes at H&R Block
A Federal Trade Commission order requires the tax prep giant to make it easier for customers to use cheaper options.
JD Supra9h
FTC Announces 2025 Thresholds for Hart-Scott-Rodino Premerger Filings and Fees
On Jan. 10, 2025, the Federal Trade Commission (FTC) announced its annual adjustments to the premerger filing thresholds under the ...
Federal Trade Commission sets closed door meeting for next Thursday
The Federal Trade Commission has scheduled a closed-door meeting for next Thursday as FTC Chair Lina Khan's reign nears an ...
FTC set to sue Deere over equipment repair practices, Bloomberg News says
The U.S. Federal Trade Commission has prepared a lawsuit against Deere & Co alleging the company's agricultural equipment ...
FTC Prepares to Sue Largest U.S. Apartment Landlord Over Hidden Fees
The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks, ...